Are colonoscopy and bowel ultrasound useful for assessing response to short-term therapy and predicting disease outcome of moderate-to-severe forms of ulcerative colitis: A prospective study

American Journal of Gastroenterology

Volumn 105, Issue 5, 2010, Pages 1150-1157

  Parente, Fabrizio ^a   Molteni, Mirko ^a   Marino, Barbara ^a   Colli, Agostino ^a   Ardizzone, Sandro ^b   Greco, Salvatore ^b   Sampietro, Gianluca ^b   Foschi, Diego ^b   Gallus, Silvano ^c  

^a A MANZONI HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; ARTICLE; COLONOSCOPY; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELAPSE; TREATMENT RESPONSE; ULCERATIVE COLITIS; ULTRASOUND;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; COHORT STUDIES; COLITIS, ULCERATIVE; COLONOSCOPY; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENDOSONOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTESTINAL MUCOSA; LOGISTIC MODELS; MALE; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951978868     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.672     Document Type: Article

References (34)

1. Lichtenstein GR, Yan S, Bala M et al. Infl iximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fi stulizing Crohn's disease. Gastroenterology 2005; 128: 862-869
2. Van Assche G, Ferrante M, Vermeire S et al. The role and importance of endoscopic mucosal healing in Crohn's disease. Gastrointest Endosc 2004; 6: 138-143
3. Daperno M, Sostegni R, Scaglione N et al. Outcome of a conservative approach in severe ulcerative colitis. Dig Liver Dis 2004; 36: 21-24
4. Rutgeerts P, Sandborn W, Feagan B et al. Infl iximab for induction and maintenance therapy of ulcerative colitis. N Engl J Med 2005; 353: 2462-2476
5. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic or unnecessary toys? Gut 2006; 55: 426-431
6. Solem CA, Loft us EV, Tremaine WJ et al. Correlation of C-reactive protein with clinical, endoscopic, histologic and radiographic activity in infl ammatory bowel disease. Infl amm Bowel Dis 2005; 11: 707-712
7. Rutgeerts P, Vermeire S, Van Assche G. Mucosal healing in infl ammatory bowel disease: impossible ideal or therapeutic target? Gut 2007; 56: 453-455
8. Parente F, Greco S, Molteni M et al. Bowel ultrasound in the diagnostic work-up and follow-up of infl ammatory bowel disease. Infl amm Bowel Dis 2004; 10: 452-461
9. Fraquelli M, Colli A, Casazza G et al. Role of US in detection of Crohn disease: meta-analysis. Radiology 2005; 236: 95-101.
10. Horsthuis K, Bipat S, Bennink RJ et al. Infl ammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008; 247: 64-79.
11. Parente F, Greco S, Molteni M et al. Role of early ultrasound in detecting infl ammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment Pharmacol Ther 2003; 18: 1009-1016
12. Epifanio M, Baldisserotto M, Spodiloro JV et al. Grey-scale and colour Doppler sonography in the evaluation of children with suspected bowel infl ammation: correlation with colonoscopy and histological fi ndings. Clin Radiol 2008; 63: 968-978
13. Maconi G, Parente F, Bollani S et al. Abdominal ultrasound in the assessment of extent and activity of Crohn's disease: clinical signifi cance and implication of bowel wall thickening. Am J Gastroenterol 1996; 91: 1604-1609
14. Mayer D, Reinshagen M, Mason RA et al. Sonographic measurement of thickened bowel wall segments as a quantitative parameter for activity in infl ammatory bowel disease. Z Gastroenterol 2000; 38: 295-300.
15. Pascu M, Roznowski AB, Muller HP et al. Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with infl ammatory bowel disease of the terminal ileum and large bowel. Infl amm Bowel Dis 2004; 10: 373-382
16. Lennard-Jones JE. Classifi cation of infl ammatory bowel disease. Scand J Gastroenterol 1989; 24 (Suppl 170): 2-6.
17. Baron JH, Connell AM, Lennard-Jones JE et al. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964; 1: 89-92.
18. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955; 2: 1041-1048
19. Parente F, Ardizzone S, Greco S et al. Response to high-dose steroids of severe attacks of ulcerative colitis may rely on bowel ultrasound instead of colonoscopy. A preliminary study. Gut 2006; 55 (Suppl V): A118.
20. Kornbluth A, Sachar D. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004; 99: 1371-1385
21. Carter MJ, Lobo AJ, Travis SPL et al. Guidelines for the management of infl ammatory bowel disease in adults. Gut 2004; 53: S1-16.
22. Oshitani N, Matsumoto T, Jinno Y et al. Prediction of short-term outcome for patients with active ulcerative colitis. Dig Dis Sci 2000; 45: 982-986
23. Faubion WA, Loft us EV, Harmsen WS et al. The natural history of corticosteroid therapy for infl ammatory bowel disease: a population-based study. Gastroenterology 2001; 121: 255-260
24. Ho GT, Chiam P, Drummond H et al. The effi cacy of corticosteroid therapy in infl ammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 2006; 24: 319-330
25. Beattie RM, Nicholls SW, Domizio P et al. Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 1996; 22: 373-379
26. Hyams J, Markowitz J, Lerer T et al. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 2006; 4: 1118-1123
27. Tung J, Loft us EV, Freese DK et al. A population-based study on the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis. Infl amm Bowel Dis 2006; 12: 1093-1100
28. Truelove SC, Watkinson G. Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis. Br Med J 1962; 5321: 1708-1711
29. Wright R, Truelove SC. Serial biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets. Am J Dig Dis 1966; 11: 1854-1858
30. Courtney MG, Nunes MB, Bergin B. Colonoscopic but not histological appearances determine likelihood of relapse of ulcerative colitis. Am J Gastroenterol 1991; 86: 243A.
31. Meucci G, Fasoli R, Saibeni S et al. Prognostic signifi cance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: preliminary results of a prospective multicenter study. Gastroenterology 2006; 130 (Suppl 2): A-197.
32. Rutgeerts P, Sandborn W, Feagan B et al. Infl iximab for induction and maintenance therapy of ulcerative colitis. N Engl J Med 2005; 353: 2462-2476
33. Martinez MJ, Ripolles T, Paredes JM et al. Assessment of the extension and the infl ammatory activity in Crohn's disease: comparison of ultrasound and MRI. Abdom Imaging 2009; 34: 141-148
34. Fraquelli M, Sarno A, Girelli C et al. Reproducibility of bowel ultrasonography in the evaluation of Crohn's disease. Dig Liver Dis 2008; 40: 860-866